株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の抗真菌薬市場:感染タイプ、薬剤タイプ、治療適応症、剤形、地域別 - 世界の分析および2027年までの予測

Antifungal Drugs Market to 2027 - Global Analysis and Forecasts By Infection Type ; Drug Type ; Therapeutic Indication ; Dosage form, and Geography

発行 The Insight Partners 商品コード 907392
出版日 ページ情報 英文 169 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
世界の抗真菌薬市場:感染タイプ、薬剤タイプ、治療適応症、剤形、地域別 - 世界の分析および2027年までの予測 Antifungal Drugs Market to 2027 - Global Analysis and Forecasts By Infection Type ; Drug Type ; Therapeutic Indication ; Dosage form, and Geography
出版日: 2019年07月31日 ページ情報: 英文 169 Pages
概要

世界の抗真菌薬市場は、2018年には101億8,230万米ドルとなりました。同市場は2019年から2027年の間に3.2%のCAGRで成長する見通しで、2027年には135億2,420万米ドルに達すると予測されています。

当レポートは世界の抗真菌薬市場について調査しており、市場機会や動向、成長および阻害要因、感染タイプ・薬剤タイプ・治療適応症・剤形・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲
  • The Insight Partnersの調査レポートガイダンス
  • 市場セグメント

第2章 要点

第3章 調査方法

  • 調査範囲
  • 二次調査
  • 一次調査

第4章 市況

  • 概要
  • PEST分析
  • 専門家の意見

第5章 主要産業の力学

  • 主な市場成長要因
  • 主な市場阻害要因
  • 主な市場機会
  • 今後の動向
  • 成長および阻害要因の影響分析

第6章 世界市場の分析

  • 市場の収益予測および分析
  • 地域別:市場予測および分析
  • 主要企業の実績
  • 主要企業の位置づけ

第7章 市場分析および2027年までの予測:感染タイプ別

  • 概要
  • 市場シェア(%):2018年&2027年
  • 表在性真菌感染
  • 全身性真菌感染

第8章 市場分析および2027年までの予測:薬剤タイプ別

  • 概要
  • 市場シェア(%):2018年&2027年
  • エキノカンジン
  • アゾール
  • ポリエン
  • アリルアミン
  • その他

第9章 市場分析および2027年までの予測:治療適応症別

  • 概要
  • 市場シェア(%):2018年&2027年
  • アスペルギルス症
  • 皮膚糸状菌症
  • カンジダ症
  • その他

第10章 市場分析および2027年までの予測:剤形別

  • 概要
  • 市場シェア(%):2018年&2027年
  • 薬物
  • 軟膏
  • パウダー
  • その他

第11章 市場分析および2027年までの予測:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東およびアフリカ
  • 中南米

第12章 業界の展望

  • 概要
  • 企業分析比較
  • 市場参入企業が成し遂げた成長戦略(%)
  • 市場参入企業が行った最近の開発(2016年~2019年)

第13章 主要企業プロファイル

  • Pfizer Inc.
  • NOVARTIS AG
  • Merck & Co., Inc.
  • GlaxoSmithKline plc.
  • Abbott
  • BAYER AG
  • SANOFI S.A
  • GILEAD SCIENCES, INC.
  • SCYNEXIS, Inc.
  • Glenmark Pharmaceuticals

章14:付録

  • The Insight Partners について
  • 用語集
図表

LIST OF TABLES

  • Table 1. Country Estimated Burden of Candidaemia
  • Table 2. North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 3. North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 4. North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 5. North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 6. US Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 7. US Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 8. US Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 9. US Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 10. Canada Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 11. Canada Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 12. Canada Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 13. Canada Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 14. Mexico Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 15. Mexico Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 16. Mexico Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 17. Mexico Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 18. Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 19. Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 20. Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 21. Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 22. UK Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 23. UK Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 24. UK Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 25. UK Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 26. Germany Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 27. Germany Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 28. Germany Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 29. Germany Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 30. France Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 31. France Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 32. France Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 33. France Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 34. Spain Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 35. Spain Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 36. Spain Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 37. Spain Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 38. Italy Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 39. Italy Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 40. Italy Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 41. Italy Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 42. Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 43. Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 44. Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 45. Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 46. China Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 47. China Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 48. China Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 49. China Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 50. Japan Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 51. Japan Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 52. Japan Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 53. Japan Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 54. India Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 55. India Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 56. India Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 57. India Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 58. Australia Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 59. Australia Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 60. Australia Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 61. Australia Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 62. South Korea Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 63. South Korea Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 64. South Korea Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 65. South Korea Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 66. Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 67. Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 68. Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 69. Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 70. UAE Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 71. UAE Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 72. UAE Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 73. UAE Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 74. Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 75. Saudi Arabia Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 76. Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 77. Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 78. South Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 79. South Africa Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 80. South Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 81. South Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 82. South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 83. South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 84. South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 85. South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 86. Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 87. Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 88. Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 89. Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 90. Argentina Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
  • Table 91. Argentina Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
  • Table 92. Argentina Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
  • Table 93. Argentina Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
  • Table 94. Recent Development Done By The Companies In The Market
  • Table 95. Glossary of Terms, Antifungal Drugs Market

LIST OF FIGURES

  • Figure 1. Antifungal Drugs Market Segmentation
  • Figure 2. Antifungal drugs Segmentation, By Region
  • Figure 3. Asia Pacific Antifungal Drugs Market, Revenue (US$ Mn), 2018 & 2027
  • Figure 4. Global Antifungal Drugs Market By Infection Type, Market Share (%), 2018
  • Figure 5. Global Antifungal Drugs Market By Drug Type, Market Share (%), 2018
  • Figure 6. Global Antifungal Drugs Market By Therapeutic Indication, Market Share (%), 2018
  • Figure 7. Global Antifungal Drugs Market By Dosage Form, Market Share (%), 2018
  • Figure 8. North America PEST Analysis
  • Figure 9. Europe PEST Analysis
  • Figure 10. Asia pacific PEST Analysis
  • Figure 11. Middle East and Africa PEST Analysis
  • Figure 12. South and Central America PEST Analysis
  • Figure 13. Antifungal Drugs Market Impact Analysis of Drivers and Restraints
  • Figure 14. Global Antifungal Drugs Market - Revenue Forecasts And Analysis - 2018- 2027
  • Figure 15. Global Antifungal Drugs Market - By Geography Forecasts And Analysis - 2018- 2027
  • Figure 16. Market Positioning Of Key Player In Global Antifungal Drugs Market
  • Figure 17. Global Antifungal Drugs Market Share by Infection Type 2018 & 2027 (%)
  • Figure 18. Superficial Fungal Infection Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 19. Systemic Fungal Infection Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 20. Global Antifungal Drugs Market Share by Drug Type 2018 & 2027 (%)
  • Figure 21. Echinocandins Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 22. Azoles Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 23. Polyenes Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 24. Allylamins Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 25. Others Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 26. Global Antifungal Drugs Market Share by Therapeutic Indication 2018 & 2027 (%)
  • Figure 27. Aspergillosis Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 28. Dermatophytosis Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 29. Candidiasis Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 30. Others Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 31. Global Antifungal drugs Market Share by Dosage Form 2018 & 2027 (%)
  • Figure 32. Dugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 33. Ointment Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 34. Powder Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 35. Others Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 36. North America Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)
  • Figure 37. North America Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 38. North America Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)
  • Figure 39. US Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 40. Canada Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 41. Mexico Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 42. Europe Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)
  • Figure 43. Europe Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 44. Europe Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)
  • Figure 45. UK Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 46. Germany Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 47. France Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 48. Spain Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 49. Italy Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 50. Asia Pacific Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)
  • Figure 51. Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
  • Figure 52. Asia Pacific Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)
  • Figure 53. China Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 54. Japan Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 55. India Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 56. Australia Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 57. South Korea Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 58. Middle East & Africa Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)
  • Figure 59. Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 60. Middle East & Africa Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)
  • Figure 61. UAE Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 62. Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 63. South Africa Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 64. South And Central America Antifungal Drugs Market Revenue Overview, By Country (2018) (US$ Mn)
  • Figure 65. South And Central America Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
  • Figure 66. South and Central America Antifungal drugs Market Revenue And Forecasts To 2027, By Country (%)
  • Figure 67. Brazil Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 68. Argentina Antifungal Drugs Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 69. Comparative Company Analysis
  • Figure 70. Growth Strategies Done By The Companies In The Market, (%)
目次
Product Code: TIPRE00003745

The global Antifungal Drugs market is expected to reach US$ 13,524.2 Mn in 2027 from US$ 10,182.3 Mn in 2018. The market is estimated to grow with a CAGR of 3.2% from 2019-2027.

The market is driven by the factors such as, rising incidences for the fungal infection of the skin, nails and hair, increasing incidences of cancers, HIV, and hospital-acquired infections and favorable government initiatives to combat the antifungal diseases are likely to drive the growth of the Antifungal Drugs market. However, lack of awareness regarding the fungal infections may restrict the growth of Antifungal Drugs market.

The significantly rising incidences of the fungal infections among others are the leading factors for the market growth.

There are millions of various types of fungi on Earth, but only around 300 are identified as the one who makes people sick. Fungal infections are mainly caused due to microscopic fungi, which is common in the atmosphere. Fungi live outside in soil and on plants and various indoor surfaces and human skin.

The rising number of fungal infections are causing harm to patients. Candidemia is among the most common bloodstream infections in the United States. For instance, according to the Centers for Disease Control and Prevention (CDC), from 2013 to 2017, the average incidence of fungal infection was around 9 per 100,000 people. Though, this number changes as per the geographic location and patient population. CDC predicts that approximately 25,000 cases of candidemia occur across the country per year.

There has been significant variation in the rates of candidemia by age group. The rates have reduced considerably in infants, but it remains higher as compared to other groups. Candidemia rates are majorly high in people aged above 65 and older. The reasons for the difference in incidence by age, race may be due to the alteration in underlying circumstances, socioeconomic status, and other factors. The prevalence of Candidaemia in established countries has been related to the age of patients. The below is the country estimated burden of Candidaemia.

Moreover, due to the tropical climate, South Asia has a high frequency of fungal infections. For instance, according to a report published by Down To Earth organization in 2015, infection from yeast, which is a type of fungus, is 0.8 among 1,000 patients in the US. Moreover, the incidence is found to be 0.2 and 0.9 per 1,000 patients in Europe and Australia, respectively. However, in India, approximately, 1-12 cases occur in every 1,000 patients that are affected by the fungal infection. Therefore, demand for the anti-fungal drugs is increasing owing to providing treatment and helps in maintaining the proper immunity to the patients. Thus, the rising rate of fungal infections are likely to drive the market for anti-fungal drugs in the coming years

Some of the major primary and secondary sources included in the report for the Antifungal Drugs market are World Health Organization, National Institute of Health and Medical Research, Centers for Disease Control and Prevention, The New England Journal of Medicine, Journal of Fungi among the others.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Antifungal Drugs Market - By Infection Type
    • 1.3.2 Global Antifungal Drugs Market - By Drug Type
    • 1.3.3 Global Antifungal Drugs Market - By Therapeutic Indication
    • 1.3.4 Global Antifungal Drugs Market - By Dosage Form
    • 1.3.5 Global Antifungal Drugs Market - By Geography

2. Global Antifungal Drugs Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Antifungal Drugs- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe- PEST Analysis
    • 4.2.3 Asia Pacific- PEST Analysis
    • 4.2.4 Middle East and Africa - PEST Analysis
    • 4.2.5 South and Central America - PEST Analysis
  • 4.3 Expert Opinion

5. Global Antifungal Drugs Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rising Prevalence of Fungal Infections
    • 5.1.2 Increasing Incidence of Cancers, HIV, and Hospital-Acquired Infections
    • 5.1.3 Favourable Government Initiatives to Combat the Antifungal Diseases
  • 5.2 Key Market Restraints
    • 5.2.1 Lack of Awareness Regarding Fungal Infections
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing Pharmaceutical Industry in Developing Regions
  • 5.4 Future Trends
    • 5.4.1 Public-Private Partnerships Agreements in the Pharmaceutical Market
  • 5.5 Impact Analysis of Drivers and Restraints

6. Antifungal Drugs Market - Global Analysis

  • 6.1 Global Antifungal Drugs Market Revenue Forecasts And Analysis
  • 6.2 Global Antifungal Drugs Market, By Geography - Forecasts And Analysis
  • 6.3 Performance Of Key Players
  • 6.4 Positioning Of Key Players

7. Antifungal Drugs Market Analysis And Forecasts To 2027 Infection Type

  • 7.1 Overview
  • 7.2 Global Antifungal Drugs Market Share by Infection Type 2018 & 2027 (%)
  • 7.3 Superficial Fungal Infection
    • 7.3.1 Overview
    • 7.3.2 Superficial Fungal Infection Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Systemic Fungal Infection
    • 7.4.1 Overview
    • 7.4.2 Systemic Fungal Infection Market Revenue and Forecast to 2027 (US$ Mn)

8. Antifungal Drugs Market Analysis And Forecasts To 2027 Drug Type

  • 8.1 Overview
  • 8.2 Global Antifungal Drugs Market Share by Drug Type 2018 & 2027 (%)
  • 8.3 Echinocandins
    • 8.3.1 Overview
    • 8.3.2 Echinocandins Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.4 Azoles
    • 8.4.1 Overview
    • 8.4.2 Azoles Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.5 Polyenes
    • 8.5.1 Overview
    • 8.5.2 Polyenes Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.6 Allylamines
    • 8.6.1 Overview
    • 8.6.2 Allylamines Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others Market Revenue and Forecast to 2027 (US$ Mn)

9. Antifungal Drugs Market Analysis And Forecasts To 2027 - Therapeutic Indication

  • 9.1 Overview
  • 9.2 Global Antifungal Drugs Market Share by Therapeutic Indication 2018 & 2027 (%)
  • 9.3 Aspergillosis
    • 9.3.1 Overview
    • 9.3.2 Aspergillosis Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.4 Dermatophytosis
    • 9.4.1 Overview
    • 9.4.2 Dermatophytosis Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.5 Candidiasis
    • 9.5.1 Overview
    • 9.5.2 Candidiasis Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)

10. Antifungal Drugs Market Analysis And Forecasts To 2027 Dosage Form

  • 10.1 Overview
  • 10.2 Global Antifungal Drugs Market Share by Dosage Form 2018 & 2027 (%)
  • 10.3 Drugs
    • 10.3.1 Overview
    • 10.3.2 Drugs Market Revenue and Forecast to 2027 (US$ Mn)
  • 10.4 Ointment
    • 10.4.1 Overview
    • 10.4.2 Ointment Market Revenue and Forecast to 2027 (US$ Mn)
  • 10.5 Powder
    • 10.5.1 Overview
    • 10.5.2 Powder Market Revenue and Forecast to 2027 (US$ Mn)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)

11. Antifungal Drugs Market Revenue And Forecasts To 2027 Regional Analysis

  • 11.1 North America Antifungal drugs Market
    • 11.1.1 Overview
    • 11.1.2 North America Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
    • 11.1.3 North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
    • 11.1.4 North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
    • 11.1.5 North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
    • 11.1.6 North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.1.7 North America Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
    • 11.1.8 US Antifungal Drugs Market
      • 11.1.8.1 US Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.8.2 US Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.1.8.3 US Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.1.8.4 US Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.1.8.5 US Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.1.9 Canada Antifungal Drugs Market
      • 11.1.9.1 Canada Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.9.2 Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.1.9.3 Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.1.9.4 Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.1.9.5 Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.1.10 Mexico Antifungal Drugs Market
      • 11.1.10.1 Mexico Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.10.2 Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.1.10.3 Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.1.10.4 Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.1.10.5 Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
  • 11.2 Europe Antifungal Drugs Market
    • 11.2.1 Overview
    • 11.2.2 Europe Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
    • 11.2.3 Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
    • 11.2.4 Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
    • 11.2.5 Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
    • 11.2.6 Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.2.7 Europe Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
    • 11.2.8 UK Antifungal Drugs Market
      • 11.2.8.1 UK Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.8.2 UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.2.8.3 UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.2.8.4 UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.2.8.5 UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.2.9 Germany Antifungal Drugs Market
      • 11.2.9.1 Germany Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.9.2 Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.2.9.3 Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.2.9.4 Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.2.9.5 Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.2.10 France Antifungal Drugs Market
      • 11.2.10.1 France Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.10.2 France Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.2.10.3 France Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.2.10.4 France Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.2.10.5 France Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.2.11 Spain Antifungal Drugs Market
      • 11.2.11.1 Spain Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.11.2 Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.2.11.3 Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.2.11.4 Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.2.11.5 Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.2.12 Italy Antifungal Drugs Market
      • 11.2.12.1 Italy Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.12.2 Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.2.12.3 Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.2.12.4 Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.2.12.5 Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
  • 11.3 Asia Pacific Antifungal Drugs Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
    • 11.3.3 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
    • 11.3.4 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
    • 11.3.5 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
    • 11.3.6 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.3.7 Asia Pacific Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
    • 11.3.8 China Antifungal Drugs Market
      • 11.3.8.1 China Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.3.8.2 China Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.3.8.3 China Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.3.8.4 China Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.3.8.5 China Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.3.9 Japan Antifungal Drugs Market
      • 11.3.9.1 Japan Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.3.9.2 Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.3.9.3 Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.3.9.4 Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.3.9.5 Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.3.10 India Antifungal Drugs Market
      • 11.3.10.1 India Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.3.10.2 India Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.3.10.3 India Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.3.10.4 India Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.3.10.5 India Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.3.11 Australia Antifungal Drugs Market
      • 11.3.11.1 Australia Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.3.11.2 Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.3.11.3 Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.3.11.4 Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.3.11.5 Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.3.12 South Korea Antifungal Drugs Market
      • 11.3.12.1 South Korea Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.3.12.2 South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.3.12.3 South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.3.12.4 South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.3.12.5 South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
  • 11.4 Middle East & Africa Antifungal Drugs Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
    • 11.4.3 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
    • 11.4.4 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
    • 11.4.5 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
    • 11.4.6 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.4.7 Middle East & Africa Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
    • 11.4.8 UAE Antifungal Drugs Market
      • 11.4.8.1 UAE Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.8.2 UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.4.8.3 UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.4.8.4 UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.4.8.5 UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.4.9 Saudi Arabia Antifungal Drugs Market
      • 11.4.9.1 Saudi Arabia Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.9.2 Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.4.9.3 Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.4.9.4 Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.4.9.5 Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.4.10 South Africa Antifungal Drugs Market
      • 11.4.10.1 South Africa Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.10.2 South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.4.10.3 South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.4.10.4 South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.4.10.5 South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
  • 11.5 South and Central America Antifungal Drugs Market
    • 11.5.1 Overview
    • 11.5.2 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
    • 11.5.3 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
    • 11.5.4 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
    • 11.5.5 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
    • 11.5.6 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.5.7 South and Central America Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
    • 11.5.8 Brazil Antifungal Drugs Market
      • 11.5.8.1 Brazil Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.5.8.2 Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.5.8.3 Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.5.8.4 Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.5.8.5 Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
    • 11.5.9 Argentina Antifungal Drugs Market
      • 11.5.9.1 Argentina Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.5.9.2 Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
      • 11.5.9.3 Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
      • 11.5.9.4 Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
      • 11.5.9.5 Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)

12. Antifungal Drugs Market- Industry Landscape

  • 12.1 Overview
  • 12.2 Comparative Company Analysis
  • 12.3 Growth Strategies Done By The Companies In The Market, (%)
  • 12.4 Recent Development Done By The Companies In The Market (2016-2019)

13. Antifungal Drugs Market-Key Company Profiles

  • 13.1 Pfizer Inc.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Financial Overview
    • 13.1.4 Product Portfolio
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 NOVARTIS AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Financial Overview
    • 13.2.4 Product Portfolio
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Merck & Co., Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Financial Overview
    • 13.3.4 Product Portfolio
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 GlaxoSmithKline plc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Financial Overview
    • 13.4.4 Product Portfolio
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Abbott
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Financial Overview
    • 13.5.4 Product Portfolio
    • 13.5.5 SWOT Analysis
  • 13.6 BAYER AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Financial Overview
    • 13.6.4 Product Portfolio
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 SANOFI S.A
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Financial Overview
    • 13.7.4 Product portfolio
    • 13.7.5 SWOT ANALYSIS
    • 13.7.6 KEY DEVELOPMENTS
  • 13.8 GILEAD SCIENCES, INC.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Financial Overview
    • 13.8.4 Product Portfolio
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 SCYNEXIS, Inc.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Financial Overview
    • 13.9.4 Product Portfolio
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Glenmark Pharmaceuticals
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Financial Overview
    • 13.10.4 Product Portfolio
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms
Back to Top